United States · FDA National Drug Code directory
Sodium phenylacetate and Sodium benzoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68475-513_1c41d0b4-cb49-468a-a9f3-6eeb22dd836f
- Product NDC
- 68475-513
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- Sodium phenylacetate and Sodium benzoate
- Labeler
- Navinta LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251206
- Source listing expiry
- 20261231
Source-listed ingredients
- SODIUM PHENYLACETATE — 100 mg/mL
- SODIUM BENZOATE — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (68475-513-01) / 20 mL in 1 VIAL · 68475-513-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →